ArticleThe Journal of biological chemistry2026

Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer.

Michael W Lero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.